Purpose
To evaluate glioblastoma (GBM) metabolism by using hyperpolarized carbon
13 (
13
C) MRI to monitor the exchange of the hyperpolarized
13
C label between injected [1-
13
C]pyruvate and
tumor lactate and bicarbonate.
Materials and Methods
In this prospective study, seven treatment-naive patients (age [mean
± SD], 60 years ± 11; five men) with GBM were imaged at 3
T by using a dual-tuned
13
C–hydrogen 1 head coil.
Hyperpolarized [1-
13
C]pyruvate was injected, and signal was
acquired by using a dynamic MRI spiral sequence. Metabolism was assessed
within the tumor, in the normal-appearing brain parenchyma (NABP), and
in healthy volunteers by using paired or unpaired
t
tests and a Wilcoxon signed rank test. The Spearman ρ correlation
coefficient was used to correlate metabolite labeling with lactate
dehydrogenase A (LDH-A) expression and some immunohistochemical markers.
The Benjamini-Hochberg procedure was used to correct for multiple
comparisons.
Results
The bicarbonate-to-pyruvate (BP) ratio was lower in the tumor than in the
contralateral NABP (
P
< .01). The tumor
lactate-to-pyruvate (LP) ratio was not different from that in the NABP
(
P
= .38). The LP and BP ratios in the NABP were
higher than those observed previously in healthy volunteers
(
P
< .05). Tumor lactate and bicarbonate
signal intensities were strongly correlated with the pyruvate signal
intensity (ρ = 0.92,
P
< .001, and
ρ = 0.66,
P
< .001, respectively), and
the LP ratio was weakly correlated with LDH-A expression in biopsy
samples (ρ = 0.43,
P
= .04).
Conclusion
Hyperpolarized
13
C MRI demonstrated variation in lactate
labeling in GBM, both within and between tumors. In contrast,
bicarbonate labeling was consistently lower in tumors than in the
surrounding NABP.
Keywords:
Hyperpolarized
13
C MRI, Glioblastoma,
Metabolism, Cancer, MRI, Neuro-oncology
Supplemental material is available for this
article.
Published under a CC BY 4.0 license.